Greater Trochanteric Pain Syndrome (Investigational)
Investigational adjunct for chronic greater trochanteric pain syndrome (gluteal tendinopathy); load management and hip-abductor strengthening remain primary.
Patienten-Zusammenfassung
- Ist dies FDA-zugelassen fuer diese Anwendung?
- Not FDA-cleared for greater trochanteric pain syndrome. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is investigational.
- Welche Evidenz existiert?
- Tier C (investigational). There are no published controlled trials. Greater trochanteric pain syndrome (lateral hip pain) most often reflects gluteus medius/minimus tendinopathy or trochanteric bursitis. Evidence-based care: activity modification, load management, hip-abductor strengthening (the strongest RCT support), gait retraining, weight management if applicable, NSAIDs for short-term symptoms, corticosteroid injection (effective short-term but limited long-term), and shock-wave therapy or PRP for refractory cases. Surgery (bursectomy, gluteus tendon repair) is reserved for refractory tendinopathy with tendon tears.
- Hauptrisiken
- Bleeding from each bite site for 6 to 24 hours after detachment
- Bruising over the lateral hip for 5 to 10 days
- Local skin or, rarely, Aeromonas hydrophila infection
- Allergic reaction to leech saliva (uncommon)
- Risk of triggering a flare if leech is placed too close to an inflamed bursa or tendon
- Septic bursitis if a contaminated bite penetrates near the trochanteric bursa
- Delay of evidence-based hip-abductor strengthening - the highest-evidence intervention
- Wer dies nicht in Betracht ziehen sollte
- Patients with suspected gluteus medius or minimus tendon tear on imaging (may need surgical evaluation)
- Patients with hip osteoarthritis, femoroacetabular impingement, or lumbar radiculopathy mimicking the syndrome
- Patients with recent corticosteroid injection at the site (within 4 weeks)
- Patients who have not completed at least 8 to 12 weeks of structured hip-abductor strengthening
- Patients on anticoagulants, with hemophilia, or with severe anemia
- Patients with active dermatitis or broken skin over the lateral hip
- Was Sie Ihren Kliniker fragen sollten
- Have I had an MRI or ultrasound to rule out gluteus tendon tear?
- Have I been worked up for hip osteoarthritis, FAI, or lumbar radiculopathy as alternatives?
- Have I completed a structured 8 to 12 week hip-abductor strengthening program with a sports-medicine-trained physical therapist?
- Have I tried corticosteroid injection, and what is its evidence vs. this investigational option?
- Where exactly will leeches be placed - confirm placement is lateral to (not directly on) the most tender point?
- What is the practitioner's plan if symptoms do not improve after 2 to 3 sessions?
- What is the Aeromonas-prevention protocol?
- Wann dringende medizinische Versorgung suchen
- Sudden inability to bear weight, hip instability, or loss of single-leg balance (possible tendon tear)
- Acute severe lateral hip swelling with warmth (possible septic bursitis)
- Calf swelling, redness, or warmth (possible DVT)
- Bleeding from a bite site lasting more than 24 hours
- Fever, chills, or spreading redness at the bite site
- Hives, facial or throat swelling, or breathing difficulty
Was dies NICHT bedeutet
- This is not FDA-cleared for greater trochanteric pain syndrome.
- No published controlled trials exist; placebo response is high in chronic overuse syndromes.
- It does not replace hip-abductor strengthening, which has the strongest RCT support.
- It does not address underlying gluteus tendon tear, which may need surgical evaluation.
- Activity modification and load management remain essential and are not substituted by procedural therapy.
Sicherheits-Querverweise
Clinical Profile
- Category
- musculoskeletal
- ICD-10
- M70.60, M70.70
- Safety tier
- medium
Evidence Summary
Greater trochanteric pain syndrome (GTPS) is most often gluteus medius and minimus insertional tendinopathy with or without trochanteric bursal involvement. Evidence-based management is education and load modification, progressive abductor strengthening (especially isometric early), with selective corticosteroid injection for short-term pain relief and PRP under investigation. The LEAP trial (Mellor et al., 2018) showed superior outcomes for exercise-plus-education versus corticosteroid injection at both 8 and 52 weeks. No controlled clinical trial of hirudotherapy for GTPS has been published; any use is investigational and mechanistic only, and the underlying gluteal tendinopathy still requires loading rehabilitation.
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)
Key Trials
- Wollina U (2008)0
Contraindications
- Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
- Hemophilia or other bleeding disorder
- Severe anemia (Hb <10 g/dL)
- Active bacteremia or sepsis
- Known hypersensitivity to leech salivary proteins
- Pregnancy (relative — first/third trimester)
- Immunocompromised state with severe neutropenia
- Hip osteoarthritis as primary diagnosis (refer to orthopedics)
- Lumbar radiculopathy with referred lateral hip pain (workup first)
- Recent corticosteroid injection at the site (within 4 weeks)
- Hip prosthesis adjacent to placement site
Related Conditions
Knee Osteoarthritis
Off-label use with three RCTs showing pain and function improvement comparable to NSAID gel at 3 months in mild-to-moderate symptomatic knee OA.
Thumb Carpometacarpal (CMC-1) Osteoarthritis
Off-label use with RCT evidence: single-session leech therapy reduces pain and improves function in CMC-1 (basal thumb) OA at 8 weeks.
Lateral Epicondylitis (Tennis Elbow)
Off-label use with two RCTs showing significant pain reduction at 7-12 weeks compared to topical NSAID and conventional physiotherapy.
Plantar Fasciitis
Off-label use with one RCT showing significant heel pain reduction at 6 weeks compared to conservative care.